Metro Inc
TSX:MRU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (24.4), the stock would be worth CA$139.41 (53% upside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 16 | CA$91.37 |
0%
|
| 3-Year Average | 24.4 | CA$139.41 |
+53%
|
| 5-Year Average | 25.5 | CA$145.48 |
+59%
|
| Industry Average | 21.5 | CA$122.8 |
+34%
|
| Country Average | 22 | CA$125.56 |
+37%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
|
Metro Inc
TSX:MRU
|
19.2B CAD | 16 | 19.1 | |
| ZA |
S
|
Shoprite Holdings Ltd
JSE:SHP
|
151.8B ZAR | 35.5 | 20 | |
| CA |
|
Alimentation Couche-Tard Inc
TSX:ATD
|
73.8B CAD | 17.4 | 19.4 | |
| CA |
|
Loblaw Companies Ltd
TSX:L
|
73.4B CAD | 28.4 | 27.4 | |
| UK |
|
Tesco PLC
LSE:TSCO
|
32.4B GBP | 28.8 | 18.1 | |
| US |
|
Kroger Co
NYSE:KR
|
43.5B USD | 18 | 43.1 | |
| NL |
|
Koninklijke Ahold Delhaize NV
AEX:AD
|
35.5B EUR | 40.5 | 15.7 | |
| IN |
|
Avenue Supermarts Ltd
NSE:DMART
|
3T INR | -390.3 | 103.7 | |
| JP |
|
Seven & i Holdings Co Ltd
TSE:3382
|
5T JPY | -33.2 | 17.1 | |
| US |
|
Caseys General Stores Inc
NASDAQ:CASY
|
30.9B USD | 97.1 | 47.6 | |
| AU |
|
Woolworths Group Ltd
ASX:WOW
|
41.7B AUD | 27.5 | 69.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.2 |
| Median | 22 |
| 70th Percentile | 36 |
| Max | 116 589.8 |
Other Multiples
Metro Inc
Glance View
Metro Inc., a stalwart in the Canadian retail landscape, navigates the competitive corridors of the grocery and pharmaceutical sectors with precision and acumen. Founded in 1947, Metro has grown from a humble beginning in Quebec to a significant force across the provinces, marking its presence with an expansive network of supermarkets, discount stores, and pharmacy outlets. The company's operations are neatly divided into two main segments: food and pharmaceuticals. Metro's grocery segment operates under well-recognized banners such as Metro, Super C, and Food Basics, offering a diverse array of products ranging from fresh produce and meats to private-label merchandise. This segment’s success hinges on Metro’s ability to adapt to consumer tastes and utilize data-driven strategies for inventory management, thereby optimizing both the customer shopping experience and logistical efficiency. Parallel to its grocery operations, Metro has built a robust pharmaceutical division through its affiliation with Jean Coutu and other pharmacy brands. This segment provides not only prescription medications but also a comprehensive suite of health, beauty, and wellness products. The synergy between the food and pharmaceutical divisions allows Metro to leverage cross-category shopping trends and customer loyalty programs, fostering a one-stop-shop format that resonates with its clientele. Revenue generation is anchored in the company's strategic pricing models, high-volume sales, and the continuous enhancement of private-label offerings, all orchestrated to maintain a balance between competitive pricing and profit margins. Through thoughtful expansions and acquisitions, Metro Inc. has crafted a diversified yet cohesive portfolio that drives sustainable growth and strengthens its positioning in the ever-evolving retail marketplace.